
Loading, please wait...

Loading, please wait...

Researchers recently introduced a breakthrough in bio-based wearable biosensing by developing a self-healing conductive fiber. This novel material, known as PPCF, utilizes poly(lactic acid diol) (PLA-diol) to balance sustainability with high performance. Consequently, it addresses the growing demand for eco-friendly medical electronics that can withstand daily wear and tear.
The PPCF features a sophisticated core-shell architecture. A nanoconductive fluid core provides stable electrical paths, while a specialized polyurethane shell ensures structural integrity. This unique design enables the fiber to heal itself autonomously after mechanical damage, much like liquid metals. Furthermore, the material maintains constant conductivity even at 200% strain. This resilience is vital for accurately monitoring dynamic physiological signals during physical activity.
Clinicians can utilize these fibers to capture both large-scale muscle movements and subtle electrophysiological changes. For instance, the fiber adheres conformally to the skin for high-fidelity, real-time heart rate monitoring. Additionally, the PPCF demonstrates rare cryogenic adaptability, functioning in environments as cold as -10 °C. Because the material is bio-based, it supports closed-loop recyclability. This feature significantly reduces the environmental impact of next-generation medical wearables.
The fiber uses a nanoconductive fluid core based on PLA-diol. This fluid can reform electrical connections across a break, while the outer polyurethane shell provides a flexible matrix that supports autonomous repair.
It can detect a wide range of signals, including heart rate (ECG), muscle activity (EMG), and joint movements. Its high sensitivity allows it to capture even subtle skin deformations.
Yes, the fiber uses bio-based segments and supports a closed-loop recycling process. This makes it a sustainable alternative to traditional petroleum-based electronic textiles.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or professional diagnostic services. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed a bio-based, self-healing conductive fiber (PPCF) that enables high-performance wearable biosensing and continuous health monitor...
6 months ago

A new case study illuminates how functional connectivity changes drive recovery from pure alexia following posterior cerebral artery infarction. Functional reorganization supports reading recovery despite permanent structural tract disconnection, highlighting key implications for stroke rehabilitation.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today